Sekar Kathiresan
Preventive Cardiology
All India Institute of Medical Sciences Raipur
About
Sekar Kathiresan works in Preventive Cardiology affiliated with All India Institute of Medical Sciences Raipur.
Sekar Kathiresan is the CEO and co-founder of Verve Therapeutics. He previously served as director of the Massachusetts General Hospital Center for Genomic Medicine and as Professor of Medicine at Harvard Medical School. His research has identified genetic mutations that influence cardiovascular disease risk.
Research focus
Genetic risk factors for heart attackProtective genetic mutations against cardiovascular diseaseTriglyceride-rich lipoproteins as therapeutic targetsPolygenic risk scores for common diseasesPrevention of myocardial infarction
Impact
441 pubs · 112,803 cites · h-index 138
Training
MD
Harvard Medical School
1997
BA
University of Pennsylvania
1992
Affiliations
Work Experience
CEO and Co-founder
Verve Therapeutics · 2019 - Present
Director, Center for Genomic Medicine
Massachusetts General Hospital · 2008 - 2019
Professor of Medicine
Harvard Medical School · 2008 - 2019
Director, Cardiovascular Disease Initiative
Broad Institute · 2008 - 2019